Advertisement

Index by author

October 01, 1986; Volume 239,Issue 1

A

  1. Adler, B

    1. Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse.
      B C Yoburn, F A Nunes, B Adler, G W Pasternak and C E Inturrisi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 132-135;

  2. Agbanyo, M

    1. Digitalis-induced mechanical toxicity: protection by slow Ca++ channel blockers.
      J C Khatter, M Agbanyo, R J Hoeschen, S Navaratnam and R Bains
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 206-210;

  3. Aguayo, L G

    1. Effects of phencyclidine and its analogs on the end-plate current of the neuromuscular junction.
      L G Aguayo and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 15-24;
    2. Blockade and recovery of the acetylcholine receptor produced by a thienyl analog of phencyclidine: influence of voltage, temperature, frequency of stimulation and conditioning pulse duration.
      L G Aguayo and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 25-31;
    3. Organophosphate and carbamate compounds have pre- and postjunctional effects at the insect glutamatergic synapse.
      M K Idriss, L G Aguayo, D L Rickett and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 279-285;

  4. Albuquerque, E X

    1. Effects of phencyclidine and its analogs on the end-plate current of the neuromuscular junction.
      L G Aguayo and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 15-24;
    2. Blockade and recovery of the acetylcholine receptor produced by a thienyl analog of phencyclidine: influence of voltage, temperature, frequency of stimulation and conditioning pulse duration.
      L G Aguayo and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 25-31;
    3. Organophosphate and carbamate compounds have pre- and postjunctional effects at the insect glutamatergic synapse.
      M K Idriss, L G Aguayo, D L Rickett and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 279-285;

  5. Aoki, K

    1. Contractile effects of Bay k 8644, a dihydropyridine calcium agonist, on isolated femoral arteries from spontaneously hypertensive rats.
      M Asano, K Aoki and T Matsuda
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 198-205;

  6. Aronstam, R S

    1. Clonidine protection from the toxicity of soman, an organophosphate acetylcholinesterase inhibitor, in the mouse.
      J J Buccafusco and R S Aronstam
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 43-47;

  7. Asano, M

    1. Contractile effects of Bay k 8644, a dihydropyridine calcium agonist, on isolated femoral arteries from spontaneously hypertensive rats.
      M Asano, K Aoki and T Matsuda
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 198-205;

B

  1. Baer, P G

    1. Treatment with dexamethasone increases glomerular prostaglandin synthesis in rats.
      A Erman, A Hassid, P G Baer and A Nasjletti
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 296-301;

  2. Bains, R

    1. Digitalis-induced mechanical toxicity: protection by slow Ca++ channel blockers.
      J C Khatter, M Agbanyo, R J Hoeschen, S Navaratnam and R Bains
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 206-210;

  3. Balkovetz, D F

    1. Inhibition of human placental Na+-H+ exchanger by cimetidine.
      V Ganapathy, D F Balkovetz, Y Miyamoto, M E Ganapathy, V B Mahesh, L D Devoe and F H Leibach
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 192-197;

  4. Barnes, P J

    1. Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung.
      J R Carstairs and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 249-255;

  5. Bass, P

    1. Ablation of the myenteric plexus impairs alpha but not beta adrenergic receptor-mediated mechanical responses of rat jejunal longitudinal muscle.
      D A Fox and P Bass
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 9-14;

  6. Belknap, J K

    1. Genetic differences in anticonvulsant sensitivity in mouse lines selectively bred for ethanol withdrawal severity.
      J C Crabbe, E R Young, B Tam, A Kosobud, J K Belknap and S E Laursen
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 154-159;

  7. Benigni, A

    1. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate.
      N Perico, C Zoja, A Benigni, F Ghilardi, L Gualandris and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 229-235;

  8. Benishin, C G

    1. Isolation of a factor (substance B) that antagonizes presynaptic modulation: pharmacological properties.
      C G Benishin, L B Pearce and J R Cooper
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 185-191;

  9. Bergman, J

    1. Some behavioral effects of histamine H1 antagonists in squirrel monkeys.
      J Bergman and R D Spealman
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 104-110;

  10. Blair, D

    1. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function.
      R T Matthews, B A McMillen, R Sallis and D Blair
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 124-131;

  11. Buccafusco, J J

    1. Clonidine protection from the toxicity of soman, an organophosphate acetylcholinesterase inhibitor, in the mouse.
      J J Buccafusco and R S Aronstam
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 43-47;

  12. Buja, L M

    1. Cellular redistribution of 45Ca in rabbit renal artery determined by electron microscopic autoradiography: changes in response to K+-induced depolarization and nitrendipine.
      E S Wheeler-Clark, G B Weiss, L J McGuffee and L M Buja
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 286-295;

C

  1. Carstairs, J R

    1. Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung.
      J R Carstairs and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 249-255;

  2. Chan, W Y

    1. Design of oxytocin antagonists with prolonged action: potential tocolytic agents for the treatment of preterm labor.
      W Y Chan, V J Hruby, T W Rockway and J Hlavacek
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 84-87;

  3. Chiu, P J

    1. Phorbol dibutyrate contractions in rabbit aorta: calcium dependence and sensitivity to nitrovasodilators and 8-BR-cyclic GMP.
      E J Sybertz, D M Desiderio, G Tetzloff and P J Chiu
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 78-83;

  4. Cho, Y H

    1. Age dependence of adenylate cyclase in guinea pig ureter homogenate.
      M A Wheeler, A Housman, Y H Cho and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 99-103;

  5. Christensen, H

    1. Tubular sites of furosemide natriuresis in volume-replaced and volume-depleted conscious rats.
      S Christensen, E Steiness and H Christensen
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 211-218;

  6. Christensen, S

    1. Tubular sites of furosemide natriuresis in volume-replaced and volume-depleted conscious rats.
      S Christensen, E Steiness and H Christensen
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 211-218;

  7. Clark, M A

    1. Leukotriene D4 receptor-mediated synthesis and release of arachidonic acid metabolites in guinea pig lung: induction of thromboxane and prostacyclin biosynthesis by leukotriene D4.
      S Mong, H L Wu, M A Clark, J G Gleason and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 63-70;

  8. Contreras, M L

    1. Kinetic analysis of the interactions of agonists and antagonists with beta adrenergic receptors.
      M L Contreras, B B Wolfe and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 136-143;

  9. Cooper, J R

    1. Isolation of a factor (substance B) that antagonizes presynaptic modulation: pharmacological properties.
      C G Benishin, L B Pearce and J R Cooper
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 185-191;

  10. Costa, E

    1. Inhibition of Met5-enkephalin-Arg6-Phe7 degradation by inhibitors of dipeptidyl carboxypeptidase.
      B Mellstrom, M J Iadarola, H Y Yang and E Costa
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 174-178;

  11. Costa, L G

    1. Carbachol- and norepinephrine-stimulated phosphoinositide metabolism in rat brain: effect of chronic cholinesterase inhibition.
      L G Costa, G Kaylor and S D Murphy
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 32-37;

  12. Crabbe, J C

    1. Genetic differences in anticonvulsant sensitivity in mouse lines selectively bred for ethanol withdrawal severity.
      J C Crabbe, E R Young, B Tam, A Kosobud, J K Belknap and S E Laursen
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 154-159;

  13. Crews, F T

    1. Correlation of ethanol's membrane actions and inhibition of receptor-stimulated histamine release from rat mast cells.
      R A Gonzales and F T Crews
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 111-116;

  14. Crooke, S T

    1. Leukotriene D4 receptor-mediated synthesis and release of arachidonic acid metabolites in guinea pig lung: induction of thromboxane and prostacyclin biosynthesis by leukotriene D4.
      S Mong, H L Wu, M A Clark, J G Gleason and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 63-70;

D

  1. Dar, M S

    1. Estrogen modulation of uterine adrenergic-cholinergic interaction: effects on vasoactivity and adrenergic receptors in the guinea pig.
      D R Garris, M M McConnaughey and M S Dar
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 270-278;

  2. DeLander, G E

    1. Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine.
      G E DeLander and C J Hopkins
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 88-93;

  3. Desiderio, D M

    1. Phorbol dibutyrate contractions in rabbit aorta: calcium dependence and sensitivity to nitrovasodilators and 8-BR-cyclic GMP.
      E J Sybertz, D M Desiderio, G Tetzloff and P J Chiu
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 78-83;

  4. Devoe, L D

    1. Inhibition of human placental Na+-H+ exchanger by cimetidine.
      V Ganapathy, D F Balkovetz, Y Miyamoto, M E Ganapathy, V B Mahesh, L D Devoe and F H Leibach
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 192-197;

  5. Di Chiara, G

    1. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol.
      A Imperato and G Di Chiara
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 219-228;

  6. Do Khac, L

    1. A re-evaluated role for cyclic AMP in uterine relaxation. Differential effect of isoproterenol and forskolin.
      L Do Khac, A Mokhtari and S Harbon
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 236-242;

E

  1. Erman, A

    1. Treatment with dexamethasone increases glomerular prostaglandin synthesis in rats.
      A Erman, A Hassid, P G Baer and A Nasjletti
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 296-301;

F

  1. Fox, D A

    1. Ablation of the myenteric plexus impairs alpha but not beta adrenergic receptor-mediated mechanical responses of rat jejunal longitudinal muscle.
      D A Fox and P Bass
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 9-14;

  2. Fukuda, S

    1. Mechanisms of extraneuronal serotonin uptake in the rat aorta.
      S Fukuda, C Su and T J Lee
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 264-269;

G

  1. Ganapathy, M E

    1. Inhibition of human placental Na+-H+ exchanger by cimetidine.
      V Ganapathy, D F Balkovetz, Y Miyamoto, M E Ganapathy, V B Mahesh, L D Devoe and F H Leibach
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 192-197;

  2. Ganapathy, V

    1. Inhibition of human placental Na+-H+ exchanger by cimetidine.
      V Ganapathy, D F Balkovetz, Y Miyamoto, M E Ganapathy, V B Mahesh, L D Devoe and F H Leibach
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 192-197;

  3. Garris, D R

    1. Estrogen modulation of uterine adrenergic-cholinergic interaction: effects on vasoactivity and adrenergic receptors in the guinea pig.
      D R Garris, M M McConnaughey and M S Dar
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 270-278;

  4. Gerber, J G

    1. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.
      A Hedberg, J G Gerber, A S Nies, B B Wolfe and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 117-123;

  5. Ghilardi, F

    1. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate.
      N Perico, C Zoja, A Benigni, F Ghilardi, L Gualandris and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 229-235;

  6. Gleason, J G

    1. Leukotriene D4 receptor-mediated synthesis and release of arachidonic acid metabolites in guinea pig lung: induction of thromboxane and prostacyclin biosynthesis by leukotriene D4.
      S Mong, H L Wu, M A Clark, J G Gleason and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 63-70;

  7. Gonzales, R A

    1. Correlation of ethanol's membrane actions and inhibition of receptor-stimulated histamine release from rat mast cells.
      R A Gonzales and F T Crews
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 111-116;

  8. Grimes, D

    1. In vitro characterization of the adrenoceptor activity of AY-28,925.
      T J Rimele, R J Heaslip, D K Lee and D Grimes
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 1-8;

  9. Gualandris, L

    1. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate.
      N Perico, C Zoja, A Benigni, F Ghilardi, L Gualandris and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 229-235;

H

  1. Harbon, S

    1. A re-evaluated role for cyclic AMP in uterine relaxation. Differential effect of isoproterenol and forskolin.
      L Do Khac, A Mokhtari and S Harbon
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 236-242;

  2. Hassid, A

    1. Treatment with dexamethasone increases glomerular prostaglandin synthesis in rats.
      A Erman, A Hassid, P G Baer and A Nasjletti
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 296-301;

  3. Hawkins, D J

    1. Phorbol diesters alter the contractile responses of porcine coronary artery.
      J R Miller, D J Hawkins and J N Wells
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 38-42;

  4. Heaslip, R J

    1. In vitro characterization of the adrenoceptor activity of AY-28,925.
      T J Rimele, R J Heaslip, D K Lee and D Grimes
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 1-8;

  5. Hedberg, A

    1. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.
      A Hedberg, J G Gerber, A S Nies, B B Wolfe and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 117-123;

  6. Hlavacek, J

    1. Design of oxytocin antagonists with prolonged action: potential tocolytic agents for the treatment of preterm labor.
      W Y Chan, V J Hruby, T W Rockway and J Hlavacek
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 84-87;

  7. Hoeschen, R J

    1. Digitalis-induced mechanical toxicity: protection by slow Ca++ channel blockers.
      J C Khatter, M Agbanyo, R J Hoeschen, S Navaratnam and R Bains
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 206-210;

  8. Hopkins, C J

    1. Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine.
      G E DeLander and C J Hopkins
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 88-93;

  9. Housman, A

    1. Age dependence of adenylate cyclase in guinea pig ureter homogenate.
      M A Wheeler, A Housman, Y H Cho and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 99-103;

  10. Hruby, V J

    1. Design of oxytocin antagonists with prolonged action: potential tocolytic agents for the treatment of preterm labor.
      W Y Chan, V J Hruby, T W Rockway and J Hlavacek
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 84-87;

  11. Husain, A

    1. Monoiodinated angiotensin II is a potent, full agonist analog of angiotensin II.
      A Husain, S F Pajka, S M Taylor and R C Speth
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 71-77;

I

  1. Iadarola, M J

    1. Inhibition of Met5-enkephalin-Arg6-Phe7 degradation by inhibitors of dipeptidyl carboxypeptidase.
      B Mellstrom, M J Iadarola, H Y Yang and E Costa
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 174-178;

  2. Idriss, M K

    1. Organophosphate and carbamate compounds have pre- and postjunctional effects at the insect glutamatergic synapse.
      M K Idriss, L G Aguayo, D L Rickett and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 279-285;

  3. Imperato, A

    1. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol.
      A Imperato and G Di Chiara
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 219-228;

  4. Inturrisi, C E

    1. Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse.
      B C Yoburn, F A Nunes, B Adler, G W Pasternak and C E Inturrisi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 132-135;

J

  1. Jarry, H

    1. Neurochemical characterization of the actions of 5-amino-2,4- dihydroxy-alpha-methylphenylethylamine (5-ADMP): a selective neurotoxin to central noradrenergic neurons.
      H Jarry, K J Lookingland, J R Palmer and K E Moore
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 55-62;

K

  1. Kajiwara, A

    1. Geographutoxin II, a novel peptide inhibitor of Na channels of skeletal muscles and autonomic nerves.
      Y Ohizumi, S Minoshima, M Takahashi, A Kajiwara, H Nakamura and J Kobayashi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 243-248;

  2. Katzman, N J

    1. CGS 8216: agonist and diazepam-antagonist effects in rodents.
      H E Shannon and N J Katzman
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 166-173;

  3. Kaylor, G

    1. Carbachol- and norepinephrine-stimulated phosphoinositide metabolism in rat brain: effect of chronic cholinesterase inhibition.
      L G Costa, G Kaylor and S D Murphy
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 32-37;

  4. Khatter, J C

    1. Digitalis-induced mechanical toxicity: protection by slow Ca++ channel blockers.
      J C Khatter, M Agbanyo, R J Hoeschen, S Navaratnam and R Bains
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 206-210;

  5. Khazaeli, M B

    1. Cardiac electrophysiologic effects of acute and chronic amiodarone administration in the isolated perfused rabbit heart: altered thyroid hormone metabolism.
      E Patterson, K M Walden, M B Khazaeli, D G Montgomery and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 179-184;

  6. Kobayashi, J

    1. Geographutoxin II, a novel peptide inhibitor of Na channels of skeletal muscles and autonomic nerves.
      Y Ohizumi, S Minoshima, M Takahashi, A Kajiwara, H Nakamura and J Kobayashi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 243-248;

  7. Kosobud, A

    1. Genetic differences in anticonvulsant sensitivity in mouse lines selectively bred for ethanol withdrawal severity.
      J C Crabbe, E R Young, B Tam, A Kosobud, J K Belknap and S E Laursen
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 154-159;

L

  1. Laursen, S E

    1. Genetic differences in anticonvulsant sensitivity in mouse lines selectively bred for ethanol withdrawal severity.
      J C Crabbe, E R Young, B Tam, A Kosobud, J K Belknap and S E Laursen
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 154-159;

  2. Lee, D K

    1. In vitro characterization of the adrenoceptor activity of AY-28,925.
      T J Rimele, R J Heaslip, D K Lee and D Grimes
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 1-8;

  3. Lee, T J

    1. Mechanisms of extraneuronal serotonin uptake in the rat aorta.
      S Fukuda, C Su and T J Lee
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 264-269;

  4. Leibach, F H

    1. Inhibition of human placental Na+-H+ exchanger by cimetidine.
      V Ganapathy, D F Balkovetz, Y Miyamoto, M E Ganapathy, V B Mahesh, L D Devoe and F H Leibach
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 192-197;

  5. Levy, G

    1. Effect of prevention of inorganic sulfate depletion on the pharmacokinetics of acetaminophen in rats.
      J H Lin and G Levy
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 94-98;

  6. Lin, J H

    1. Effect of prevention of inorganic sulfate depletion on the pharmacokinetics of acetaminophen in rats.
      J H Lin and G Levy
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 94-98;

  7. Lookingland, K J

    1. Neurochemical characterization of the actions of 5-amino-2,4- dihydroxy-alpha-methylphenylethylamine (5-ADMP): a selective neurotoxin to central noradrenergic neurons.
      H Jarry, K J Lookingland, J R Palmer and K E Moore
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 55-62;

  8. Lucchesi, B R

    1. Cardiac electrophysiologic effects of acute and chronic amiodarone administration in the isolated perfused rabbit heart: altered thyroid hormone metabolism.
      E Patterson, K M Walden, M B Khazaeli, D G Montgomery and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 179-184;

  9. Luchowski, E M

    1. Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscle.
      X Y Wei, E M Luchowski, A Rutledge, C M Su and D J Triggle
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 144-153;

  10. Lyddane, J E

    1. Modification of behavioral effects and biodisposition of phencyclidine in rats by ammonium chloride.
      B F Thomas, J E Lyddane and B R Martin
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 48-54;

M

  1. Mahesh, V B

    1. Inhibition of human placental Na+-H+ exchanger by cimetidine.
      V Ganapathy, D F Balkovetz, Y Miyamoto, M E Ganapathy, V B Mahesh, L D Devoe and F H Leibach
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 192-197;

  2. Martin, B R

    1. Modification of behavioral effects and biodisposition of phencyclidine in rats by ammonium chloride.
      B F Thomas, J E Lyddane and B R Martin
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 48-54;

  3. Matsuda, T

    1. Contractile effects of Bay k 8644, a dihydropyridine calcium agonist, on isolated femoral arteries from spontaneously hypertensive rats.
      M Asano, K Aoki and T Matsuda
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 198-205;

  4. Matthews, R T

    1. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function.
      R T Matthews, B A McMillen, R Sallis and D Blair
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 124-131;

  5. McConnaughey, M M

    1. Estrogen modulation of uterine adrenergic-cholinergic interaction: effects on vasoactivity and adrenergic receptors in the guinea pig.
      D R Garris, M M McConnaughey and M S Dar
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 270-278;

  6. McGuffee, L J

    1. Cellular redistribution of 45Ca in rabbit renal artery determined by electron microscopic autoradiography: changes in response to K+-induced depolarization and nitrendipine.
      E S Wheeler-Clark, G B Weiss, L J McGuffee and L M Buja
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 286-295;

  7. McMillen, B A

    1. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function.
      R T Matthews, B A McMillen, R Sallis and D Blair
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 124-131;

  8. Mellstrom, B

    1. Inhibition of Met5-enkephalin-Arg6-Phe7 degradation by inhibitors of dipeptidyl carboxypeptidase.
      B Mellstrom, M J Iadarola, H Y Yang and E Costa
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 174-178;

  9. Miller, J R

    1. Phorbol diesters alter the contractile responses of porcine coronary artery.
      J R Miller, D J Hawkins and J N Wells
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 38-42;

  10. Minoshima, S

    1. Geographutoxin II, a novel peptide inhibitor of Na channels of skeletal muscles and autonomic nerves.
      Y Ohizumi, S Minoshima, M Takahashi, A Kajiwara, H Nakamura and J Kobayashi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 243-248;

  11. Miyamoto, Y

    1. Inhibition of human placental Na+-H+ exchanger by cimetidine.
      V Ganapathy, D F Balkovetz, Y Miyamoto, M E Ganapathy, V B Mahesh, L D Devoe and F H Leibach
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 192-197;

  12. Mokhtari, A

    1. A re-evaluated role for cyclic AMP in uterine relaxation. Differential effect of isoproterenol and forskolin.
      L Do Khac, A Mokhtari and S Harbon
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 236-242;

  13. Molinoff, P B

    1. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.
      A Hedberg, J G Gerber, A S Nies, B B Wolfe and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 117-123;
    2. Kinetic analysis of the interactions of agonists and antagonists with beta adrenergic receptors.
      M L Contreras, B B Wolfe and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 136-143;

  14. Mong, S

    1. Leukotriene D4 receptor-mediated synthesis and release of arachidonic acid metabolites in guinea pig lung: induction of thromboxane and prostacyclin biosynthesis by leukotriene D4.
      S Mong, H L Wu, M A Clark, J G Gleason and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 63-70;

  15. Montgomery, D G

    1. Cardiac electrophysiologic effects of acute and chronic amiodarone administration in the isolated perfused rabbit heart: altered thyroid hormone metabolism.
      E Patterson, K M Walden, M B Khazaeli, D G Montgomery and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 179-184;

  16. Moore, K E

    1. Neurochemical characterization of the actions of 5-amino-2,4- dihydroxy-alpha-methylphenylethylamine (5-ADMP): a selective neurotoxin to central noradrenergic neurons.
      H Jarry, K J Lookingland, J R Palmer and K E Moore
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 55-62;

  17. Murphy, S D

    1. Carbachol- and norepinephrine-stimulated phosphoinositide metabolism in rat brain: effect of chronic cholinesterase inhibition.
      L G Costa, G Kaylor and S D Murphy
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 32-37;

N

  1. Nakamura, H

    1. Geographutoxin II, a novel peptide inhibitor of Na channels of skeletal muscles and autonomic nerves.
      Y Ohizumi, S Minoshima, M Takahashi, A Kajiwara, H Nakamura and J Kobayashi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 243-248;

  2. Nasjletti, A

    1. Treatment with dexamethasone increases glomerular prostaglandin synthesis in rats.
      A Erman, A Hassid, P G Baer and A Nasjletti
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 296-301;

  3. Navaratnam, S

    1. Digitalis-induced mechanical toxicity: protection by slow Ca++ channel blockers.
      J C Khatter, M Agbanyo, R J Hoeschen, S Navaratnam and R Bains
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 206-210;

  4. Nies, A S

    1. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.
      A Hedberg, J G Gerber, A S Nies, B B Wolfe and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 117-123;

  5. Nunes, F A

    1. Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse.
      B C Yoburn, F A Nunes, B Adler, G W Pasternak and C E Inturrisi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 132-135;

O

  1. Ohizumi, Y

    1. Geographutoxin II, a novel peptide inhibitor of Na channels of skeletal muscles and autonomic nerves.
      Y Ohizumi, S Minoshima, M Takahashi, A Kajiwara, H Nakamura and J Kobayashi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 243-248;

P

  1. Pajka, S F

    1. Monoiodinated angiotensin II is a potent, full agonist analog of angiotensin II.
      A Husain, S F Pajka, S M Taylor and R C Speth
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 71-77;

  2. Palmer, J R

    1. Neurochemical characterization of the actions of 5-amino-2,4- dihydroxy-alpha-methylphenylethylamine (5-ADMP): a selective neurotoxin to central noradrenergic neurons.
      H Jarry, K J Lookingland, J R Palmer and K E Moore
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 55-62;

  3. Pasternak, G W

    1. Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse.
      B C Yoburn, F A Nunes, B Adler, G W Pasternak and C E Inturrisi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 132-135;

  4. Patterson, E

    1. Cardiac electrophysiologic effects of acute and chronic amiodarone administration in the isolated perfused rabbit heart: altered thyroid hormone metabolism.
      E Patterson, K M Walden, M B Khazaeli, D G Montgomery and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 179-184;

  5. Pearce, L B

    1. Isolation of a factor (substance B) that antagonizes presynaptic modulation: pharmacological properties.
      C G Benishin, L B Pearce and J R Cooper
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 185-191;

  6. Perico, N

    1. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate.
      N Perico, C Zoja, A Benigni, F Ghilardi, L Gualandris and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 229-235;

R

  1. Remuzzi, G

    1. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate.
      N Perico, C Zoja, A Benigni, F Ghilardi, L Gualandris and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 229-235;

  2. Rickett, D L

    1. Organophosphate and carbamate compounds have pre- and postjunctional effects at the insect glutamatergic synapse.
      M K Idriss, L G Aguayo, D L Rickett and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 279-285;

  3. Rimele, T J

    1. In vitro characterization of the adrenoceptor activity of AY-28,925.
      T J Rimele, R J Heaslip, D K Lee and D Grimes
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 1-8;

  4. Rockway, T W

    1. Design of oxytocin antagonists with prolonged action: potential tocolytic agents for the treatment of preterm labor.
      W Y Chan, V J Hruby, T W Rockway and J Hlavacek
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 84-87;

  5. Rutledge, A

    1. Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscle.
      X Y Wei, E M Luchowski, A Rutledge, C M Su and D J Triggle
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 144-153;

S

  1. Sallis, R

    1. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function.
      R T Matthews, B A McMillen, R Sallis and D Blair
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 124-131;

  2. Samanin, R

    1. Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments.
      A Vezzani, H Q Wu, M Tullii and R Samanin
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 256-263;

  3. Shannon, H E

    1. CGS 8216: agonist and diazepam-antagonist effects in rodents.
      H E Shannon and N J Katzman
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 166-173;

  4. Spealman, R D

    1. Some behavioral effects of histamine H1 antagonists in squirrel monkeys.
      J Bergman and R D Spealman
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 104-110;

  5. Speth, R C

    1. Monoiodinated angiotensin II is a potent, full agonist analog of angiotensin II.
      A Husain, S F Pajka, S M Taylor and R C Speth
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 71-77;

  6. Steiness, E

    1. Tubular sites of furosemide natriuresis in volume-replaced and volume-depleted conscious rats.
      S Christensen, E Steiness and H Christensen
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 211-218;

  7. Su, C

    1. Mechanisms of extraneuronal serotonin uptake in the rat aorta.
      S Fukuda, C Su and T J Lee
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 264-269;

  8. Su, C M

    1. Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscle.
      X Y Wei, E M Luchowski, A Rutledge, C M Su and D J Triggle
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 144-153;

  9. Sybertz, E J

    1. Phorbol dibutyrate contractions in rabbit aorta: calcium dependence and sensitivity to nitrovasodilators and 8-BR-cyclic GMP.
      E J Sybertz, D M Desiderio, G Tetzloff and P J Chiu
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 78-83;

T

  1. Takahashi, M

    1. Geographutoxin II, a novel peptide inhibitor of Na channels of skeletal muscles and autonomic nerves.
      Y Ohizumi, S Minoshima, M Takahashi, A Kajiwara, H Nakamura and J Kobayashi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 243-248;

  2. Tam, B

    1. Genetic differences in anticonvulsant sensitivity in mouse lines selectively bred for ethanol withdrawal severity.
      J C Crabbe, E R Young, B Tam, A Kosobud, J K Belknap and S E Laursen
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 154-159;

  3. Taylor, S M

    1. Monoiodinated angiotensin II is a potent, full agonist analog of angiotensin II.
      A Husain, S F Pajka, S M Taylor and R C Speth
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 71-77;

  4. Tetzloff, G

    1. Phorbol dibutyrate contractions in rabbit aorta: calcium dependence and sensitivity to nitrovasodilators and 8-BR-cyclic GMP.
      E J Sybertz, D M Desiderio, G Tetzloff and P J Chiu
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 78-83;

  5. Thomas, B F

    1. Modification of behavioral effects and biodisposition of phencyclidine in rats by ammonium chloride.
      B F Thomas, J E Lyddane and B R Martin
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 48-54;

  6. Triggle, D J

    1. Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscle.
      X Y Wei, E M Luchowski, A Rutledge, C M Su and D J Triggle
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 144-153;

  7. Tseng, L F

    1. Stereoselective effect of beta-endorphin on the production of analgesia and the spinal release of met-enkephalin in rats.
      L F Tseng
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 160-165;

  8. Tullii, M

    1. Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments.
      A Vezzani, H Q Wu, M Tullii and R Samanin
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 256-263;

V

  1. Vezzani, A

    1. Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments.
      A Vezzani, H Q Wu, M Tullii and R Samanin
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 256-263;

W

  1. Walden, K M

    1. Cardiac electrophysiologic effects of acute and chronic amiodarone administration in the isolated perfused rabbit heart: altered thyroid hormone metabolism.
      E Patterson, K M Walden, M B Khazaeli, D G Montgomery and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 179-184;

  2. Wei, X Y

    1. Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscle.
      X Y Wei, E M Luchowski, A Rutledge, C M Su and D J Triggle
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 144-153;

  3. Weiss, G B

    1. Cellular redistribution of 45Ca in rabbit renal artery determined by electron microscopic autoradiography: changes in response to K+-induced depolarization and nitrendipine.
      E S Wheeler-Clark, G B Weiss, L J McGuffee and L M Buja
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 286-295;

  4. Weiss, R M

    1. Age dependence of adenylate cyclase in guinea pig ureter homogenate.
      M A Wheeler, A Housman, Y H Cho and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 99-103;

  5. Wells, J N

    1. Phorbol diesters alter the contractile responses of porcine coronary artery.
      J R Miller, D J Hawkins and J N Wells
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 38-42;

  6. Wheeler, M A

    1. Age dependence of adenylate cyclase in guinea pig ureter homogenate.
      M A Wheeler, A Housman, Y H Cho and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 99-103;

  7. Wheeler-Clark, E S

    1. Cellular redistribution of 45Ca in rabbit renal artery determined by electron microscopic autoradiography: changes in response to K+-induced depolarization and nitrendipine.
      E S Wheeler-Clark, G B Weiss, L J McGuffee and L M Buja
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 286-295;

  8. Wolfe, B B

    1. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.
      A Hedberg, J G Gerber, A S Nies, B B Wolfe and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 117-123;
    2. Kinetic analysis of the interactions of agonists and antagonists with beta adrenergic receptors.
      M L Contreras, B B Wolfe and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 136-143;

  9. Wu, H L

    1. Leukotriene D4 receptor-mediated synthesis and release of arachidonic acid metabolites in guinea pig lung: induction of thromboxane and prostacyclin biosynthesis by leukotriene D4.
      S Mong, H L Wu, M A Clark, J G Gleason and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 63-70;

  10. Wu, H Q

    1. Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments.
      A Vezzani, H Q Wu, M Tullii and R Samanin
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 256-263;

Y

  1. Yang, H Y

    1. Inhibition of Met5-enkephalin-Arg6-Phe7 degradation by inhibitors of dipeptidyl carboxypeptidase.
      B Mellstrom, M J Iadarola, H Y Yang and E Costa
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 174-178;

  2. Yoburn, B C

    1. Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse.
      B C Yoburn, F A Nunes, B Adler, G W Pasternak and C E Inturrisi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 132-135;

  3. Young, E R

    1. Genetic differences in anticonvulsant sensitivity in mouse lines selectively bred for ethanol withdrawal severity.
      J C Crabbe, E R Young, B Tam, A Kosobud, J K Belknap and S E Laursen
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 154-159;

Z

  1. Zoja, C

    1. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate.
      N Perico, C Zoja, A Benigni, F Ghilardi, L Gualandris and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics October 1986, 239 (1) 229-235;
Back to top

In this issue

Advertisement